Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005)
Open Access
- 18 April 2007
- journal article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 7 (1) , 29
Abstract
Daptomycin is a cyclic lipopeptide with potent activity and broad spectrum against Gram-positive bacteria currently used for the treatment of complicated skin and skin structure infections and bacteremia, including right sided endocarditis. We evaluated the in vitro activity of this compound and selected comparator agents tested against clinical strains of staphylococci and enterococci collected in European medical centers in 2005.Keywords
This publication has 44 references indexed in Scilit:
- Daptomycin Bactericidal Activity and Correlation between Disk and Broth Microdilution Method Results in Testing of Staphylococcus aureus Strains with Decreased Susceptibility to VancomycinAntimicrobial Agents and Chemotherapy, 2006
- Antimicrobial activity of daptomycin tested against clinical strains of indicated species isolated in North American medical centers (2003)Diagnostic Microbiology and Infectious Disease, 2005
- Global Spread of Vancomycin-resistantEnterococcus faeciumfrom Distinct Nosocomial Genetic ComplexEmerging Infectious Diseases, 2005
- Activity of Glycopeptides against Staphylococcus aureus Infection in a Rabbit Endocarditis Model: MICs Do Not Predict In Vivo EfficacyAntimicrobial Agents and Chemotherapy, 2005
- Antimicrobial activity of daptomycin against multidrug-resistant gram-positive strains collected worldwideDiagnostic Microbiology and Infectious Disease, 2004
- Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolidInternational Journal of Antimicrobial Agents, 2004
- Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002)Diagnostic Microbiology and Infectious Disease, 2004
- Staphylococcus aureus with Reduced Susceptibility to VancomycinClinical Infectious Diseases, 2004
- DaptomycinDrugs, 2004
- In Vitro Activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a Challenge Panel of Staphylococci and Enterococci, Including Vancomycin-Intermediate Staphylococcus aureus and Vancomycin-Resistant Enterococcus faeciumMicrobial Drug Resistance, 2003